Cargando…
Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy
Background: The purpose of this study is to evaluate the utility and safety of plasma rich in growth factors immunosafe eye drops (is-ePRGF) in the postoperative treatment of non-penetrating deep sclerectomy (NPDS). Methods: This is a case–control study in patients with open-angle glaucoma. Group on...
Autores principales: | Rodríguez-Calvo, Pedro P., Rodríguez-Uña, Ignacio, Fernández-Vega-Cueto, Andrés, Sánchez-Ávila, Ronald M., Anitua, Eduardo, Merayo-Lloves, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219153/ https://www.ncbi.nlm.nih.gov/pubmed/37240710 http://dx.doi.org/10.3390/jcm12103604 |
Ejemplares similares
-
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
por: Sánchez-Avila, Ronald M, et al.
Publicado: (2018) -
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2021) -
Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases
por: Anitua, Eduardo, et al.
Publicado: (2022) -
Fibrin-Plasma Rich in Growth Factors Membrane for the Treatment of a Rabbit Alkali-Burn Lesion
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2021) -
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
por: de la Sen-Corcuera, Borja, et al.
Publicado: (2020)